Paracetamol
Brand names: Panadol, Calpol, Perfalgan (IV)
Paracetamol (acetaminophen) is a widely used analgesic and antipyretic for mild-to-moderate pain and fever, available over the counter and as a prescription medicine.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Its precise mechanism is incompletely understood but is thought to involve central inhibition of prostaglandin synthesis, with little peripheral anti-inflammatory effect.
Prescribing in practice
- Overdose causes potentially fatal hepatotoxicity; counsel patients not to exceed the recommended maximum daily intake and to check that other combination products do not also contain paracetamol.
- Dose reduction or extended dosing intervals are advised in hepatic impairment, chronic alcohol use, low body weight and other risk factors for liver injury.
- Acute overdose is managed urgently with acetylcysteine guided by serum paracetamol levels and a treatment nomogram; refer to current poisoning guidance.
Monitoring
Routine monitoring is not required at therapeutic doses, but liver function and paracetamol levels are checked after suspected overdose.
Counselling the patient
- Do not take more than the stated dose, and do not combine multiple paracetamol-containing products.
- Seek urgent medical help after any overdose even if you feel well.
- Tell a clinician if you drink alcohol regularly or have liver problems.
Evidence & guidelines
Paracetamol is a long-established first-line agent for pain and fever recommended across UK and international guidelines.
Reference: MHRA Paracetamol Overdose Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.